← Back to Clinical Trials
Recruiting NCT07457710

NCT07457710 Remote Haptic Rehabilitation for Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07457710
Status Recruiting
Phase
Sponsor Virginia Polytechnic Institute and State University
Condition Parkinson's Disease (PD)
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-03-25
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Haptic deviceNon-haptic device

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-03-25 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Individuals with Parkinson's Disease (PD) often have motor difficulties that can negatively impact daily activities and their quality of life. Research has shown that to slow the progression of these symptoms, patients should partake in effective physical rehabilitation. However, effective physical rehabilitation has many barriers, including timing, cost, and other personal or system-level challenges. The purpose of this study is to evaluate the haptic remote rehabilitation system for patients with PD using a randomized controlled trial (RCT) in a field environment.

Eligibility Criteria

Inclusion Criteria: * Over 18 years old * Diagnosed with PD Exclusion Criteria: * Hoehn and Yahr stage outside 1-3 * Lives outside the 48 contiguous states in the USA * Unable to move hands and head without assistance * Unable to remain seated in an upright position for up to an hour

Contact & Investigator

Central Contact

Sol Lim, Ph.D.

✉ sol@vt.edu

📞 540-231-0083

Principal Investigator

Sol Lim, Ph.D.

PRINCIPAL INVESTIGATOR

Virginia Polytechnic Institute and State University

Frequently Asked Questions

Who can join the NCT07457710 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07457710 currently recruiting?

Yes, NCT07457710 is actively recruiting participants. Contact the research team at sol@vt.edu for enrollment information.

Where is the NCT07457710 trial being conducted?

This trial is being conducted at Blacksburg, United States.

Who is sponsoring the NCT07457710 clinical trial?

NCT07457710 is sponsored by Virginia Polytechnic Institute and State University. The principal investigator is Sol Lim, Ph.D. at Virginia Polytechnic Institute and State University. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology